| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |